Glycosaminoglycans in thyroid eye disease

Thyroid

Volumn 8, Issue 5, 1998, Pages 429-432

  Kahaly, George ^a   Förster, Gregor ^a   Hansen, Christiane ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHONDROITIN 4 SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HYALURONIC ACID;

CONFERENCE PAPER; CONTROLLED STUDY; EXOPHTHALMOS; EXTRACELLULAR MATRIX; EYE DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0031746751     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.429     Document Type: Conference Paper

References (16)

1. Hartley GB, Gorman CA 1995 Perspective. Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol 119:792-795.
2. Burch HB, Wartofsky L 1993 Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endoer Rev 14:747-791.
3. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA 1996 The chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:426-434.
4. Wight TN, Heinegard DK, Hascall VC 1991 Proteoglycans, structure and function. In: Hay ED (ed) Cell Biology of Extracellular Matrix, 2nd edition. Plenum Press, New York, pp 45-78.
5. Poulsen JH 1986 Urine and tissue glycosaminoglycans and their interrelations. Dan Med Bull 33:75-96.
6. Aruffo A, Stamenkovic I, Melnick M, Underbill CB, Seed B 1990 CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313.
7. Hansen C, Otto E, Beyer J, Kahaly G 1996 Aberrant distribution of glycosaminoglycans in Graves' ophthalmopathy analysed by a high specific HPLC method. J Endocrinol 148:OC28.
8. Hansen Ch, Rouhi R, Förster G, Kahaly G 1997 HPLC-analysis of orbital glycosaminoglycans in Graves' ophthalmopathy. Thyroid 7(1):S75.
9. Hansen C, Otto E, Kuhlemann K, Förster G, Kahaly G 1996 Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol 14(15):59-67.
10. Yanagishita M, Midura RJ, Hascall VC 1987 Proteoglycans: Isolation and purification from tissue cultures. Methods Enzymol 138:279-289.
11. Staprans I, Garon SJ, Hopper J Jr, Felts JM 1981 Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects and their effects on lipoprotein lipase. Biochim Biophys Acta 678:414-422.
12. Tan GH, Button CM, Bahn RS 1996 Interleukin 1 (IL 1) receptor antagonist and soluble IL 1 receptor inhibit IL 1 induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 81:449-452.
13. Smith TJ, Bahn RS, Gorman CA 1989 Connective tissue, glycosaminoglycans, and disease of the thyroid. Endocr Rev 10:366-391.
14. Kahaly G, Hansen C, Stover C, Beyer J, Otto E 1993 Glycosaminoglycan antibodies in endocrine ophthalmopathy. Horm Metab Res 25:637-639.
15. Tsao M, Ferrarini M, Evans C, Ambro A, Whiteside TL 1989 Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells. Clin Immunol Immunopathol 50:122-131.
16. Conrad P, Rothmann BL, Kelly KA, Blue ML 1992 Mechanism of peripheral T cell activation by coengagement of CD44 and CD2. J Immunol 149:1830-1833.